SANUWAVE Health, Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for SANUWAVE Health, Inc. (SNWV), the latest P/E of 2.7 frames valuation, while ROE 1728.10% and ROIC 2.80% indicates profitability and capital efficiency. Together with the current ratio of 1.28 and debt-to-equity 7.43, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

SNWV Historical Per Share Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Revenue per Share$5.10$7.31$9.64$11.43$9.41$4.02$0.01$0.01$0.01$0.01
Net Income per Share$1.66$-7.03$-12.19$-7.02$-19.72$-30.68$-0.05$-0.08$-0.04$-0.06
Operating Cash Flow per Share$0.61$0.55$-2.14$-11.72$-4.64$-12.61$-0.03$-0.02$-0.01$-0.03
Free Cash Flow per Share$0.72$0.44$-2.14$-11.02$-5.02$-12.67$-0.03$-0.02$-0.01$-0.03
Cash per Share$1.09$2.29$0.85$0.79$0.45$2.42$0.01$0.00$0.01$0.00
Book Value per Share$0.32$-2.85$-20.40$-27.99$-28.18$-13.61$-0.05$-0.10$-0.07$-0.06
Tangible Book Value per Share$-0.86$-5.31$-25.92$-36.45$-37.66$-27.30$-0.05$-0.10$-0.07$-0.06
Interest Debt per Share$2.82$8.77$22.47$37.70$24.09$19.95$0.04$0.10$0.05$0.05
CAPEX per Share$0.11$0.11$0.00$0.70$0.38$0.05$0.00$0.00$0.00$0.00

SNWV Historical Valuation Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Price to Earnings (P/E)2.66-3.27-0.4-1.22-3.23-2.26-1171.19-1108.86-2275.14-1096.25
Price to Book (P/B)13.73-8.07-0.24-0.31-2.26-5.1-1213.81-839.9-1275.16-1021.3
Price to Sales (P/S)0.873.150.510.756.7717.2411874.146971.4717060.455129.7
Enterprise Value to EBITDA2.57-7.12-4.4210.95-6.02-3.11-1432.36-1814.74-2881.68-2361.43
EV to Sales1.133.611.983.138.7420.9711879.166977.117067.655133.61
EV to Operating Cash Flow9.548.03-8.92-3.06-17.74-6.69-1906.24-3564.61-8244.05-2207.93
EV to Free Cash Flow8.0260-8.92-3.25-16.39-6.66-1890.34-3522.88-8244.05-2200.8
Enterprise Value$49.60M$117.91M$40.46M$52.48M$113.70M$85.09M$12.22B$12.91B$12.60B$7.06B

SNWV Historical Profitability Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Return on Equity (ROE)1728.10%246.69%59.77%25.10%69.97%225.51%103.64%75.74%56.05%93.16%
Return on Invested Capital (ROIC)2.80%41.45%4.96%-271.65%116.35%-646.56%403.05%159.55%99.78%328.36%
Return on Tangible Assets54.10%-164.00%-240.69%-137.68%-494.00%-335.45%-308.39%-987.61%-433.05%-640.78%
Earnings Yield37.39%-30.56%-250.32%-82.16%-30.93%-44.23%-0.09%-0.09%-0.04%-0.09%
Free Cash Flow Yield16.17%1.91%-44.02%-128.89%-7.87%-18.26%-0.05%-0.03%-0.01%-0.05%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

SNWV Historical Liquidity & Financial Strength

10 years
Metric (FY)TTM202420232022202120202019201820172016
Current Ratio1.280.430.150.110.080.220.20.070.110.12
Interest Coverage0.190.4-0.03-0.63-1.99-9.92-4.79-1.6-3.360
Income Quality2.09-0.190.181.670.240.410.610.310.280.5
Debt to Equity7.43-2-0.74-1-0.67-1.28-0.69-0.7-0.61-0.8
Debt to Assets56.57%84.65%142.51%206.84%140.73%76.34%204.74%916.30%472.94%549.47%
Net Debt to EBITDA0.59-0.92-3.298.34-1.35-0.55-0.61-1.47-1.22-1.8

SNWV Historical Efficiency Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Receivables Turnover7.579.86.164.165.391.7213.627.844.842.99
Payables Turnover3.292.171.060.980.650.260.370.440.160.79
Inventory Turnover1.541.952.054.994.790.390.991.941.052.44
Days Sales Outstanding48.2337.2359.387.8467.75211.9426.846.5675.38122.23
Days Payables Outstanding110.88168.32345.04370.82559.581399.04974.88838.032257.43460.48
Days of Inventory on Hand236.99187.33178.4873.1576.13928.61367.73188.28349.25149.81

SNWV Historical Market Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Enterprise Value to EBITDA2.57-7.12-4.4210.95-6.02-3.11-1432.36-1814.74-2881.68-2361.43
Market Cap$38.27M$102.65M$10.31M$12.53M$88.12M$69.95M$12.22B$12.90B$12.60B$7.06B
Enterprise Value$49.60M$117.91M$40.46M$52.48M$113.70M$85.09M$12.22B$12.91B$12.60B$7.06B
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does SANUWAVE Health, Inc.’s P/E ratio compare with its history?

On this page, SNWV's current P/E is 2.7, compared with a multi-year average around 2.7. When the current P/E sits near its historical average, the multiple is close to that range. Look at trend direction in profitability and cash-flow rows, plus liquidity and leverage, rather than treating the P/E in isolation.

What is SANUWAVE Health, Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $38.27M. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does SANUWAVE Health, Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with SANUWAVE Health, Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does SANUWAVE Health, Inc. compare to its competitors in key financial ratios?

The fastest way to compare SANUWAVE Health, Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see SANUWAVE Health, Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do SANUWAVE Health, Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that SANUWAVE Health, Inc. is financially strong. Current ratio is about 1.28, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 0.19, implying less buffer for servicing interest costs. Debt-to-equity is about 7.43, suggesting higher leverage than a low-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do SANUWAVE Health, Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If SANUWAVE Health, Inc. is sustaining strong returns (for example ROE at 1728.10% and ROIC at 2.80%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.